GW PHARMACEUTICALS PLC GWPH Balance Sheet

Gw pharmaceuticals plc (GWPH)

Balance Sheet / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Sep'17
Assets
Cash and cash equivalents
500,935	536,933	554,682	583,683	521,669	591,497	354,913	322,154
Accounts receivable, net
62,209	48,883	41,818	32,113	19,251	4,192	2,122	1,367
Inventory
89,056	85,528	69,288	60,042	48,559	33,030	19,061	5,669
Prepaid expenses and other current assets
20,546	28,292	32,196	21,693	19,389	17,903	14,615	35,392
Total current assets
672,746	699,636	697,984	697,531	608,868	646,622	390,711	364,582
Property, plant, and equipment, net
122,882	127,765	110,161	107,332	102,029	90,832	82,381	63,175
Operating lease assets
23,199	24,916	20,438	18,739	20,077	-	-	-
Intangible assets
5,951	-	-	-	-	-	-	-
Goodwill
6,959	6,959	6,959	6,959	6,959	6,959	6,959	6,959
Deferred tax assets
18,123	18,123	8,425	8,726	8,584	8,720	7,334	6,805
Other assets
4,517	4,850	3,884	3,490	3,040	2,935	3,150	1,401
Total assets
854,377	882,249	847,851	842,777	749,557	756,068	490,535	442,922
Liabilities and stockholders’ equity
Accounts payable
18,345	9,990	6,934	11,757	10,794	9,796	9,741	7,757
Accrued liabilities
77,479	99,374	81,704	66,434	59,782	52,477	46,739	33,656
Current tax liabilities
998	437	-	-	1,730	2,384	1,385	1,119
Other current liabilities
6,650	7,760	6,627	5,757	5,651	1,559	804	2,377
Total current liabilities
103,472	117,561	95,265	83,948	77,957	66,216	58,669	44,909
Long-term liabilities:
Finance lease liabilities
5,157	5,573	5,297	5,536	5,801	5,690	1,535	1,741
Operating lease liabilities
20,028	21,650	17,007	15,139	16,374	-	-	-
Build-to-suit financing obligation
-	-	-	-	-	-	4,378	4,611
Other liabilities
10,715	11,431	10,627	9,262	9,696	10,082	10,794	10,838
Total long-term liabilities
35,900	38,654	32,931	29,937	31,871	15,772	16,707	17,190
Total liabilities
139,372	156,215	128,196	113,885	109,828	81,988	75,376	62,099
Stockholders’ equity:
Common stock - Ordinary shares par value £0.001; 372,562,088 shares outstanding as of March 31, 2020; 371,068,436 shares outstanding as of December 31, 2019
573	570	570	570	567	564	530	482
Additional paid-in capital
1,643,407	1,632,046	1,619,649	1,607,346	1,593,056	1,581,144	1,246,857	916,726
Accumulated deficit
-845,924	-837,959	-813,013	-799,256	-879,004	-828,940	-757,034	-461,867
Accumulated other comprehensive loss
-83,051	-68,623	-87,551	-79,768	-74,890	-78,688	-75,194	-74,518
Total stockholders’ equity
715,005	726,034	719,655	728,892	639,729	674,080	415,159	380,823
Total liabilities and stockholders’ equity
854,377	882,249	847,851	842,777	749,557	756,068	490,535	442,922